Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.82 - $26.01 $272,890 - $377,145
-14,500 Reduced 51.06%
13,900 $316,000
Q2 2024

Aug 14, 2024

SELL
$18.54 - $24.31 $20,394 - $26,741
-1,100 Reduced 3.73%
28,400 $602,000
Q1 2024

May 15, 2024

SELL
$22.04 - $28.86 $454,024 - $594,516
-20,600 Reduced 41.12%
29,500 $705,000
Q4 2023

Feb 14, 2024

BUY
$12.39 - $24.0 $275,058 - $532,800
22,200 Added 79.57%
50,100 $1.16 Million
Q3 2023

Nov 14, 2023

SELL
$17.64 - $34.52 $63,504 - $124,272
-3,600 Reduced 11.43%
27,900 $521,000
Q2 2023

Aug 14, 2023

BUY
$28.01 - $34.23 $641,429 - $783,866
22,900 Added 266.28%
31,500 $976,000
Q1 2023

May 15, 2023

BUY
$30.66 - $39.48 $91,980 - $118,439
3,000 Added 53.57%
8,600 $277,000
Q4 2022

Feb 14, 2023

SELL
$22.29 - $35.34 $57,954 - $91,884
-2,600 Reduced 31.71%
5,600 $181,000
Q3 2022

Nov 14, 2022

SELL
$21.92 - $29.19 $852,688 - $1.14 Million
-38,900 Reduced 82.59%
8,200 $209,000

Others Institutions Holding PHR

About Phreesia, Inc.


  • Ticker PHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 52,532,200
  • Market Cap $1.07B
  • Description
  • Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a ra...
More about PHR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.